Effect of cardiopulmonary bypass (cpb) time on the degree of platelet dysfunction

Philip E. Greilich, Ramaswamy Ravi Kumar

Research output: Contribution to journalArticle

Abstract

Platelet dysfunction during CPB is felt to result from a combination of decreased platelet concentration due to hemodilution, and platelet injury (activation, receptor loss) due to extensive exposure to the foreign surface of the membrane oxygenator used during extra-corporeal circulation. Since the platelet injury component should depend on the extent of exposure, the degree of platelet dysfunction should increase as the duration of CPB increases. This study tested whether point-of-care devices, that could be used in the operating room, are capable of detecting increasing degrees of platelet dysfunction as a function of CPB time. After signed informed consent, twenty-four patients undergoing CPB surgery were enrolled in an IRB approved protocol. Platelet function was studied at baseline (prior to CPB) and again within two hours of completion of CPB. All patients received aminocaproic acid as prophylactic antifibrinolytic therapy. Whole blood platelet aggregation, platelet contractile force and thromboelastography (MAg-shear elastic modulus) were measured. The post-CPB values were calculated as percent of the baseline and plotted versus CPB time. Impedance aggregometry decreased with increasing CPB time. The decrease in platelet aggregation 2-4 hours post-CPB correlated (r=0.66;p<0.05) with the duration of CPB. Platelet contractile force also decreased with increasing CPB time. The decrease in platelet contractile force from samples collected post CPB significantly correlated (r=0.68;p<0.05) with the duration of CPB. The MAg of the thromboelastogram decreased with increasing CPB time. The decrease in MAg from samples collected post CPB significantly correlated (r=0.54;p<0.05) with the duration of CPB. These findings confirm that the length of CPB is a direct determinant of the degree of platelet dysfunction and that techniques currently available to study platelet function in the operating room can detect the degree of dysfunction.

Original languageEnglish (US)
JournalBlood
Volume96
Issue number11 PART II
StatePublished - 2000

Fingerprint

Platelets
Cardiopulmonary Bypass
Blood Platelets
Operating rooms
Operating Rooms
Platelet Aggregation
Point-of-Care Systems
Membrane Oxygenators
Thrombelastography
Agglomeration
Aminocaproic Acid
Oxygenators
Antifibrinolytic Agents
Hemodilution
Elastic Modulus
Research Ethics Committees
Platelet Activation
Wounds and Injuries
Informed Consent
Electric Impedance

ASJC Scopus subject areas

  • Hematology

Cite this

Effect of cardiopulmonary bypass (cpb) time on the degree of platelet dysfunction. / Greilich, Philip E.; Kumar, Ramaswamy Ravi.

In: Blood, Vol. 96, No. 11 PART II, 2000.

Research output: Contribution to journalArticle

@article{974acfa4f3f9436390f19a61977e241f,
title = "Effect of cardiopulmonary bypass (cpb) time on the degree of platelet dysfunction",
abstract = "Platelet dysfunction during CPB is felt to result from a combination of decreased platelet concentration due to hemodilution, and platelet injury (activation, receptor loss) due to extensive exposure to the foreign surface of the membrane oxygenator used during extra-corporeal circulation. Since the platelet injury component should depend on the extent of exposure, the degree of platelet dysfunction should increase as the duration of CPB increases. This study tested whether point-of-care devices, that could be used in the operating room, are capable of detecting increasing degrees of platelet dysfunction as a function of CPB time. After signed informed consent, twenty-four patients undergoing CPB surgery were enrolled in an IRB approved protocol. Platelet function was studied at baseline (prior to CPB) and again within two hours of completion of CPB. All patients received aminocaproic acid as prophylactic antifibrinolytic therapy. Whole blood platelet aggregation, platelet contractile force and thromboelastography (MAg-shear elastic modulus) were measured. The post-CPB values were calculated as percent of the baseline and plotted versus CPB time. Impedance aggregometry decreased with increasing CPB time. The decrease in platelet aggregation 2-4 hours post-CPB correlated (r=0.66;p<0.05) with the duration of CPB. Platelet contractile force also decreased with increasing CPB time. The decrease in platelet contractile force from samples collected post CPB significantly correlated (r=0.68;p<0.05) with the duration of CPB. The MAg of the thromboelastogram decreased with increasing CPB time. The decrease in MAg from samples collected post CPB significantly correlated (r=0.54;p<0.05) with the duration of CPB. These findings confirm that the length of CPB is a direct determinant of the degree of platelet dysfunction and that techniques currently available to study platelet function in the operating room can detect the degree of dysfunction.",
author = "Greilich, {Philip E.} and Kumar, {Ramaswamy Ravi}",
year = "2000",
language = "English (US)",
volume = "96",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11 PART II",

}

TY - JOUR

T1 - Effect of cardiopulmonary bypass (cpb) time on the degree of platelet dysfunction

AU - Greilich, Philip E.

AU - Kumar, Ramaswamy Ravi

PY - 2000

Y1 - 2000

N2 - Platelet dysfunction during CPB is felt to result from a combination of decreased platelet concentration due to hemodilution, and platelet injury (activation, receptor loss) due to extensive exposure to the foreign surface of the membrane oxygenator used during extra-corporeal circulation. Since the platelet injury component should depend on the extent of exposure, the degree of platelet dysfunction should increase as the duration of CPB increases. This study tested whether point-of-care devices, that could be used in the operating room, are capable of detecting increasing degrees of platelet dysfunction as a function of CPB time. After signed informed consent, twenty-four patients undergoing CPB surgery were enrolled in an IRB approved protocol. Platelet function was studied at baseline (prior to CPB) and again within two hours of completion of CPB. All patients received aminocaproic acid as prophylactic antifibrinolytic therapy. Whole blood platelet aggregation, platelet contractile force and thromboelastography (MAg-shear elastic modulus) were measured. The post-CPB values were calculated as percent of the baseline and plotted versus CPB time. Impedance aggregometry decreased with increasing CPB time. The decrease in platelet aggregation 2-4 hours post-CPB correlated (r=0.66;p<0.05) with the duration of CPB. Platelet contractile force also decreased with increasing CPB time. The decrease in platelet contractile force from samples collected post CPB significantly correlated (r=0.68;p<0.05) with the duration of CPB. The MAg of the thromboelastogram decreased with increasing CPB time. The decrease in MAg from samples collected post CPB significantly correlated (r=0.54;p<0.05) with the duration of CPB. These findings confirm that the length of CPB is a direct determinant of the degree of platelet dysfunction and that techniques currently available to study platelet function in the operating room can detect the degree of dysfunction.

AB - Platelet dysfunction during CPB is felt to result from a combination of decreased platelet concentration due to hemodilution, and platelet injury (activation, receptor loss) due to extensive exposure to the foreign surface of the membrane oxygenator used during extra-corporeal circulation. Since the platelet injury component should depend on the extent of exposure, the degree of platelet dysfunction should increase as the duration of CPB increases. This study tested whether point-of-care devices, that could be used in the operating room, are capable of detecting increasing degrees of platelet dysfunction as a function of CPB time. After signed informed consent, twenty-four patients undergoing CPB surgery were enrolled in an IRB approved protocol. Platelet function was studied at baseline (prior to CPB) and again within two hours of completion of CPB. All patients received aminocaproic acid as prophylactic antifibrinolytic therapy. Whole blood platelet aggregation, platelet contractile force and thromboelastography (MAg-shear elastic modulus) were measured. The post-CPB values were calculated as percent of the baseline and plotted versus CPB time. Impedance aggregometry decreased with increasing CPB time. The decrease in platelet aggregation 2-4 hours post-CPB correlated (r=0.66;p<0.05) with the duration of CPB. Platelet contractile force also decreased with increasing CPB time. The decrease in platelet contractile force from samples collected post CPB significantly correlated (r=0.68;p<0.05) with the duration of CPB. The MAg of the thromboelastogram decreased with increasing CPB time. The decrease in MAg from samples collected post CPB significantly correlated (r=0.54;p<0.05) with the duration of CPB. These findings confirm that the length of CPB is a direct determinant of the degree of platelet dysfunction and that techniques currently available to study platelet function in the operating room can detect the degree of dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=33748535782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748535782&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748535782

VL - 96

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11 PART II

ER -